News & Impact

You are here

News for Motor Recovery

Showing 13 - 18 of 78 total
Spot a stroke fast, face, arm, speech, time to call 911
NEWS: 
Article
Stroke affects over 795,000 people in the U.S. alone each year, that is one person every 40 seconds. Dr. Tomoko Kitago, lab director of the Human Motor Recovery Laboratory at the Burke Neurological Institute, talks about stroke awareness, treatments and the importance of clinical trials.
2021 National Cerebral Palsy Awareness Research Award recipient Dr. Kathleen Friel and Friel Lab
NEWS: 
Award
Awarded By: 
Cerebral Palsy Foundation
To conclude National Cerebral Palsy Awareness Month, the Cerebral Palsy Foundation announced with great honor, Dr. Kathleen Friel of the Burke Neurological Institute is the 2021 National Cerebral Palsy Awareness Research Award recipient.
Person walking and field of tulips
NEWS: 
Article
A diagnosis of Parkinson’s Disease can be quite challenging for patients and their families. Since April is Parkinson’s Disease Awareness Month, it’s a perfect time to highlight the importance of exercise in reducing symptoms and improving quality of life in people living with PD.
Kathleen working
NEWS: 
Article
Building a culture of inclusion is an ongoing journey, we are committed to honoring diverse minds and beliefs held by all. With great honor, Dr. Kathleen M. Friel, a brilliant scientist and a key influencer in changing the future of cerebral palsy, shares with us her insightful perspective on the need for cerebral palsy awareness, the demand for CP research, going beyond science, and what you can do.
Photo of Raj, Saravanan, Amit, and Yingxin
NEWS: 
Article
The research team examined how myeloid cells can also facilitate repair by clearing debris and promoting tissue remodeling during the early stages of repair. The study showed that a transcription factor, hypoxia-inducible factor, which the Ratan lab has been studying for years, marks myeloid cells that are associated with good long term recovery.
Zhong Lab returning to lab
NEWS: 
Article
We are proud to be a strong team dedicated to spinal cord injury research, and proud to embark on our first phase I clinical trial soon.